New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
08:21 EDTFB, GOOGFacebook acquisition ensures new opportunities, says JMP Securities
After Facebook (FB) acquired virtual reality firm Oculus, JMP Securities thinks Facebook's expansion into virtual reality will creates new opportunities for it over the next 5-10 years. The firm sees parallels between the Oculus deal and Google's (GOOG) acquisition of Android in 2005. JMP Securities identifies Facebook as a top pick and reiterates an Outperform rating on the stock.
News For FB;GOOG From The Last 14 Days
Check below for free stories on FB;GOOG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
July 15, 2014
10:33 EDTFBFacebook, Twitter slip following cautious valuation comments from Fed
Shares of a number of companies in the social media and biotech industries moved lower following the circulation of cautious comments about their stock valuations that were included in the Federal Reserve's latest Monetary Policy Report. WHAT'S NEW: In the report, presented by the Board of Governors of the Federal Reserve and signed on behalf of the governors by Chair Janet Yellen, the central bank wrote that some broad equity price indexes have increased to all-time highs in nominal terms since the end of 2013, but that valuation measures for the overall market in early July were "generally at levels not far above their historical averages." However, the Fed's report also cautioned that valuation metrics in some sectors do appear substantially "stretched," particularly those for smaller firms in the social media and biotechnology industries, despite a notable downturn in equity prices for such firms early in the year. As support for its assessment, the Fed noted that ratios of prices to forward earnings for "smaller firms as well as social media and biotechnology firms" remain "high relative to historical norms." PRICE ACTION: Following the circulation of the comments in the Fed report, shares of Facebook (FB) are down 88c, or 1.3%, to $67.02, Twitter (TWTR) is down 24c, or 0.6%, to $38.07 and LinkedIn (LNKD), is down 21c, or 0.1%, to $159.57. Shares of some biotechnology companies including Celgene (CELG) and Amgen (AMGN) also ticked lower following the circulation of the comments from the Fed's report.
10:18 EDTFBFacebook, Twitter move lower following comments from Yellen
Subscribe for More Information
10:00 EDTGOOGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:38 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FB JPM TSLA
07:23 EDTFBFortune to hold a conference
Subscribe for More Information
07:15 EDTGOOGIIR Holdings to hold a conference
14th Annual Shopper Insights in Action Conference to be held in Chicago on July 14-16.
06:15 EDTGOOGGoogle Fit may benefit remote medical care industry, DigiTimes Research says
Subscribe for More Information
06:13 EDTFBFacebook, Nielsen team up to track TV habits, LA Times reports
Subscribe for More Information
06:02 EDTGOOGSamsung, Nest, ARM team up for Thread wireless networking protocol
Subscribe for More Information
05:44 EDTGOOGNovartis to license Google 'smart lens' technology
Novartis (NVS) announced that its eye care division Alcon has entered into an agreement with a division of Google (GOOG) to in-license its "smart lens" technology for all ocular medical uses. The agreement with Google[x], a team within Google that is devoted to finding new solutions to big global problems, provides Alcon with the opportunity to develop and commercialize Google's "smart lens" technology with the potential to transform eye care and further enhance Alcon's pipeline and global leadership in contact lenses and intraocular lenses. The transaction remains subject to anti-trust approvals. The agreement between Google and Alcon represents an important step for Novartis, across all of its divisions, to leverage technology to manage human diseases and conditions. Google's key advances in the miniaturization of electronics complement Novartis's deep pharmaceuticals and medical device expertise. Novartis aims to enhance the ways in which diseases are mapped within the body and ultimately prevented.
July 14, 2014
18:49 EDTGOOGGoogle initiated with an Outperform at FBR Capital
Subscribe for More Information
16:00 EDTFB, GOOGOptions Update; July 14, 2014
Subscribe for More Information
10:15 EDTGOOGAmazon hires Google Glass creator Babak Parviz, TechCrunch reports
Subscribe for More Information
09:36 EDTFBActive equity options trading on open
Subscribe for More Information
09:25 EDTFB, GOOGGoogle looked to Page, Brin to woo Facebook workers, WSJ says
Subscribe for More Information
08:10 EDTGOOGEndurance announces extension of partnership with Google
Endurance International Group (EIGI) announced the extension of its partnership with Google (GOOG) for the Get Your Business Online initiative. The partnership will allow more businesses to benefit from the overall web presence solutions the program provides. The Get Your Business Online program has already provided web presence services and support to bring hundreds of thousands of American businesses online for the first time.
07:22 EDTFBFacebook poised to report stronger than expected Q2 results, says Oppenheimer
Subscribe for More Information
06:10 EDTGOOGTaiwan touch panel makers see more orders from handset vendors, DigiTimes says
Subscribe for More Information
July 13, 2014
17:00 EDTGOOGYouTube mulls funding production to add premium content, Reuters says
Subscribe for More Information
July 12, 2014
15:59 EDTGOOGGoogle expands in San Francisco, San Jose Mercury News says
Google is building out its presence in San Francisco by leasing space in one location and buying an office tower on the Embarcadero, says San Jose Mercury News. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use